Landos Biopharma, Inc. Quarterly Current Ratio in % from Q3 2021 to Q1 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Landos Biopharma, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q1 2024.
  • Landos Biopharma, Inc. Current Ratio for the quarter ending March 31, 2024 was 730 %, a 20.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 730 -186 -20.3% Mar 31, 2024
Q4 2023 941 +257 +37.5% Dec 31, 2023
Q3 2023 986 +358 +56.9% Sep 30, 2023
Q2 2023 1.02K +357 +53.4% Jun 30, 2023
Q1 2023 916 +214 +30.4% Mar 31, 2023
Q4 2022 685 -180 -20.8% Dec 31, 2022
Q3 2022 628 -204 -24.5% Sep 30, 2022
Q2 2022 667 Jun 30, 2022
Q1 2022 702 Mar 31, 2022
Q4 2021 864 Dec 31, 2021
Q3 2021 832 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.